New Key Statistics Module, Z-Score and F-Score
SHSE:600062 Key Ratios
Market Cap ¥ M | 24,036.87 |
Enterprise Value ¥ M | 20,950.18 |
P/E(ttm) | 17.28 |
PE Ratio without NRI | 16.28 |
Forward PE Ratio | -- |
Price/Book | 2.09 |
Price/Sales | 2.27 |
Price/Free Cash Flow | 19.64 |
Price/Owner Earnings | 23.36 |
Payout Ratio % | 0.20 |
Revenue (TTM) ¥ M | 10,284.00 |
EPS (TTM) ¥ | 1.34 |
Beneish M-Score | -2.51 |
10-y EBITDA Growth Rate % | 5.10 |
5-y EBITDA Growth Rate % | 7.70 |
y-y EBITDA Growth Rate % | 9.60 |
EV-to-EBIT | 12.87 |
EV-to-EBITDA | 12.87 |
PEG | 2.11 |
Shares Outstanding M | 1,039.66 |
Net Margin (%) | 13.36 |
Operating Margin % | 15.26 |
Pre-tax Margin (%) | 15.69 |
Quick Ratio | 2.15 |
Current Ratio | 2.61 |
ROA % (ttm) | 9.04 |
ROE % (ttm) | 12.63 |
ROIC % (ttm) | 14.24 |
Dividend Yield % | 1.24 |
Altman Z-Score | 6.50 |
SHSE:600062 Number of Guru Trades
SHSE:600062 Volume of Guru Trades
Gurus Latest Trades with SHSE:600062
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600062 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
China Resources Double-Crane Pharmaceutical Co Ltd Insider Transactions
No Available Data